PU21.03 Assessment of crosslinker suitability for fusion peptide conjugates as priming immunogens for an HIV-1 vaccinePublication OnlyNovel vaccine and other prevention approaches
PU21.06 DNA vs ChAd-vectored vaccines as priming vaccines in heterologous prime-boost regimens to increase HTI immunogenicity in micePublication OnlyNovel vaccine and other prevention approaches
PU21.08 Distinct classes of HIV-1 cross-clade neutralizing antibodies targeting fusion peptide elicited in mice by diverse immunization regimensPublication OnlyNovel vaccine and other prevention approaches
OA05.04 Disruption of immune cell homeostasis within rectal mucosal tissue of HIV+ young men who have sex with menOral Abstract SessionMucosal immunity
OA09.02 Anti-Env antibody-independent protection of repeated intrarectal low-dose SIVmac239 challenges in rhesus macaques by vaccination inducing Gag/Vif-specific CD8+ T but not CD4+ T cellsOral Abstract SessionMucosal immunity
OA19.03 Transcriptional analysis of cervical cell populations reveals inflammatory signatures and differential epithelial keratinization associated with Depo-Provera useOral Abstract SessionMucosal immunity
OA20.04 Tissue-resident memory CD4+ T cells in ectocervical versus endocervical specimensOral Abstract SessionMucosal immunity
OA22.03 Temporal and spatial characterization of SIV infection dynamics in rhesus macaque mucosal tissuesOral Abstract SessionMucosal immunity
OA22.05 The impact of penile-vaginal sex on penile immune correlates of HIV susceptibilityOral Abstract SessionMucosal immunity
PE20.03 Mucosal responses to HIV-1 co-infection with an emerging pathogen, Zika virusE-posterMucosal immunity
seek-warrow-warrow-eseek-e91 - 100 of 444 items